|
Variables
|
Exercise group
|
Dopamine agonists group
|
Placebo group
|
|---|
|
EMCL CSA (cm
2
)
| | | |
|
Baseline
|
13.9±5.1
|
7.6±2.1
|
10.0±5.2
|
|
6-m post
|
11.2±5.8
|
6.8±3.6
|
9.4±2.0
|
|
Δ Change
|
−2.62±5.15
|
−0.79±3.33
|
−0.61±3.92
|
|
95% CI of Δ Change
|
−5.46 to 0.22
|
−3.86 to 2.21
|
−4.23 to 3.01
|
|
EMCL (%)
| | | |
|
Baseline
|
10.9±3.8
|
8.7±3.6
|
8.7±3.9
|
|
6-m post
|
8.2±3.5†
|
7.1±2.7
|
8.4±1.5
|
|
Δ Change
|
−2.70±3.90
|
−1.65±3.45
|
−0.21±3.54
|
|
95% CI of Δ Change
|
−4.85 to −0.55
|
−4.83 to 1.53
|
−3.48 to 3.06
|
|
Muscle CSA (cm
2
)
| | | |
|
Baseline
|
99.5±14.5
|
82.5±22.5
|
98.9±7.3
|
|
6-m post
|
106.8±24.4
|
89.4±24.5
|
95.8±2.0
|
|
Δ Change
|
7.32±16.03
|
6.93±17.66
|
- 3.15±7.87
|
|
95% CI of Δ Change
|
16.18 to −1.54
|
23.22 to −9.39
|
−10.42 to 4.12
|
|
Muscle (%)
| | | |
|
Baseline
|
87.9±3.7
|
85.7±7.2
|
88.1±3.9
|
|
6-m post
|
88.9±4.5
|
88.1±5.9
|
88.2 ±2.2
|
|
Δ Change
|
0.96±5.50
|
2.39±4.89
|
0.07±1.64
|
|
95% CI of Δ Change
|
4.00 to −2.04
|
8.90 to −2.12
|
1.58 to −1.44
|
|
SAT CSA (cm
2
)
| | | |
|
Baseline
|
142.8±57.8
|
88.7±46.7
|
103.6±28.4
|
|
6-m post
|
143.8±64.8
|
95.5±39.3
|
99.7±14.9
|
|
Δ Change
|
0.98±18.88
|
6.80±19.34
|
−3.95±17.97
|
|
95% CI of Δ Change
|
11.42 to −9.46
|
24.67 to −11.07
|
−20.55 to 12.65
|
- All data are mean ± SD. Abbreviations: EMCL Extramyocellular lipids (fat infiltration), CSA Cross sectional area, SAT Subcutaneous adipose tissue.
-
†Significantly different from the respective baseline value.
